Use of 3-deoxyanthocyanidins for treating occular diseases
US10513503B2 · kind B2 · utility
1Cited by
1References
7Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 27, 2016 |
| Grant date | Dec 24, 2019 |
| Priority date | — |
| Expiry date | May 27, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P27/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed is a method for the treatment, prevention and/or stabilisation of ARMD, Stargardt disease, pigmentary retinopathy and/or diabetic retinopathy, including the application of a 3-deoxyanthocyanidin of formula (I) in which R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11 and X− are as defined, with the condition that at least one of R1, R2, R3, R4 or R5 is a hydroxyl and at least one of R8, R9, R10 or R11 is a hydroxyl.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.